Researchers Find NCCN Criteria For Genetic Testing In Breast Cancer May Miss 45 Percent Of Patients With Clinically Actionable Germ-Line Variants.

MedPage Today (2/24, Bankhead) reports women who did not meet National Comprehensive Cancer Network (NCCN) “criteria for genetic testing in breast cancer had a prevalence of potentially pathogenic mutations” of 7.9 percent, while among those who did meet...